Concepedia
Statistics
Publications
11
Citations
238
H-Index
10
Active since
2019
Affiliations
University of Minnesota, Duluth(Current)
University of Nebraska Medical Center
Nebraska Medical Center
Texas Tech University
University of Ha'il
Shirisha Jonnalagadda is an author at University of Minnesota, Duluth specializing in medicine, oncology, and drug discovery.
Publications per year
2019–2024
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Chinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy et al. · Breast Cancer Research · 2019 · 67 citations · Full text
Medicine, Oncology, Pharmacology +17
Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors
Shirisha Jonnalagadda, Sravan K. Jonnalagadda, Conor T. Ronayne et al. · Oncotarget · 2019 · 35 citations · Full text
Medicine, Medicinal Chemistry, Oncology +13
A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma
Ali Khammanivong, Jhuma Saha, Angela Spartz et al. · Veterinary and Comparative Oncology · 2019 · 21 citations
Medicine, Oncology, Pharmacology +12
Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment
Grady L. Nelson, Conor T. Ronayne, Lucas N. Solano et al. · Scientific Reports · 2019 · 20 citations · Full text
Medicine, Oncology, Pharmacology +15
Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents
Lucas N. Solano, Grady L. Nelson, Conor T. Ronayne et al. · Scientific Reports · 2020 · 17 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 11